Barrigel Injectable Gel
510(k) K220641Ref 011507
Active
Valid until
No date given
FDA recalls
None found
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| European Union | CE/MDD EUDAMED | NumberB-00850004725061 00850004725061 | Date19 May 2026 | StatusActive |
| United States | FDA 510(k)SESE 510(k) | NumberK220641 | Date26 May 2022 | StatusActive |
Official records
- EUDAMED public site B-00850004725061
- FDA 510(k) database K220641
From the FDA record
- Received by the FDA
- 4 Mar 2022
- FDA decision
- 26 May 2022 (Substantially Equivalent)
- FDA review time
- 83 days from receipt to decision
- Public document
- 510(k) summary on file with the FDA
Across registries
- EUDAMED Basic UDI-DI B-00850004725061 registered 19 May 2026 Active
- FDA 510(k) K220641 decided 26 May 2022 Active
Timeline
- Cleared FDA 510(k) K220641
- Registered EUDAMED B-00850004725061
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
- European Union
- United States
Specification
- Device name
- Barrigel Syringe (3ml)
- Model / reference
- 011507
- FDA applicant
- Palette Life Sciences
- Primary DI / UDI-DI
- 00850004725061
- Basic UDI-DI
- B-00850004725061
- 510(k) Number
- FDA product code
- OVB
- EMDN code
- T030499 Radiotherapy protection devices - other
- Device class
- Class III EUDAMEDClass II 510(k)
- Regulation
- 21 CFR Part 892.5725
- EU registration type
- Legacy device (under a directive)
- EU market of registration
- Ireland
- Advisory committee
- Radiology
- FDA decision
- SESE Substantially Equivalent
Truth per registry
| Field | EUDAMED | 510(k) |
|---|---|---|
| Device class | Class III | Class II |
Overview
AI-generated summary, 18 Sep 2026
The Barrigel Injectable Gel is a Hydrogel Spacer, a radiopaque, injectable substance designed to create space between anatomical structures. It is formulated to provide temporary separation, particularly in radiology procedures where maintaining tissue separation is critical, such as in breast augmentation or reconstruction.
This device is supplied as a sterile, single-use injectable gel intended for use in radiology settings. It is classified as a Class II medical device under FDA regulations and adheres to the Medical Device Directive (MDD) in the EU. The gel is packaged in sterile, pre-filled syringes and must be stored under controlled conditions as specified by the manufacturer to ensure sterility and efficacy.
Devices cleared under K220641
Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.
| UDI-DI | Size and differences | |||
|---|---|---|---|---|
| Barrigel 011508 | 011508 / 011508 | 00850004725108 | Total Volume 3 mL | On the market |
| Barrigel 3016-1 | 3016-1 / 3016-1 | 00850004725139 | Total Volume 3 mL | On the market |
| Barrigel Applicator Needle 3009-2 | 3009-2 / 3009-2 | 00850004725115 | Needle Gauge 18 G; Length 20 cm | On the market |
Similar devices in this category
Other devices filed under RADIOTHERAPY PROTECTION DEVICES - OTHER.
- Bolus Gel, 15x20x1cm BL-9610 by LIEVENS-LANCKMAN BV
- QLRAD 105.2000 by QLRAD INTERNATIONAL LTD
- Bolus Gel, 15x20x0,5cm BL-9605 by LIEVENS-LANCKMAN BV
- X-ray Protection Device 0001 by Cangzhou Youmeiyou Rubber Products Co., Ltd.
- QLRAD 105.3000 by QLRAD INTERNATIONAL LTD
- RadTrac® 00884450203231 by Merit Medical Systems, Inc.
- RadBoard®Xtra™ 00884450203200 by Merit Medical Systems, Inc.